

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 5.68099780 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 5.68099780 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 4.68306232 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.68306232 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.62773220 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 4.62773220 |
| 7 | regulation of cholesterol homeostasis (GO:2000188) | 4.43617832 |
| 8 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.30987516 |
| 9 | protein carboxylation (GO:0018214) | 4.30987516 |
| 10 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.29620737 |
| 11 | positive regulation of nuclease activity (GO:0032075) | 4.20825202 |
| 12 | protein localization to endosome (GO:0036010) | 4.19886862 |
| 13 | negative regulation of fibrinolysis (GO:0051918) | 4.14292280 |
| 14 | lysine metabolic process (GO:0006553) | 4.10574133 |
| 15 | lysine catabolic process (GO:0006554) | 4.10574133 |
| 16 | hemidesmosome assembly (GO:0031581) | 4.06522718 |
| 17 | 4-hydroxyproline metabolic process (GO:0019471) | 4.00694676 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 3.94384221 |
| 19 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.90194008 |
| 20 | oxaloacetate metabolic process (GO:0006107) | 3.89381424 |
| 21 | negative regulation of cell size (GO:0045792) | 3.88627123 |
| 22 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.82454988 |
| 23 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.82278749 |
| 24 | kynurenine metabolic process (GO:0070189) | 3.81168286 |
| 25 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.80101533 |
| 26 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.79681568 |
| 27 | tricarboxylic acid metabolic process (GO:0072350) | 3.78680136 |
| 28 | 2-oxoglutarate metabolic process (GO:0006103) | 3.77892828 |
| 29 | regulation of nuclease activity (GO:0032069) | 3.76705629 |
| 30 | aromatic amino acid family catabolic process (GO:0009074) | 3.74477491 |
| 31 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.71939170 |
| 32 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.69886349 |
| 33 | protein retention in ER lumen (GO:0006621) | 3.62728578 |
| 34 | sulfur amino acid catabolic process (GO:0000098) | 3.61361713 |
| 35 | COPII vesicle coating (GO:0048208) | 3.60871823 |
| 36 | valine metabolic process (GO:0006573) | 3.59424618 |
| 37 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.57565103 |
| 38 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.57427954 |
| 39 | cell-substrate junction assembly (GO:0007044) | 3.53121054 |
| 40 | glyoxylate metabolic process (GO:0046487) | 3.52544865 |
| 41 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.48218486 |
| 42 | intestinal cholesterol absorption (GO:0030299) | 3.46667355 |
| 43 | negative regulation of sterol transport (GO:0032372) | 3.43576519 |
| 44 | negative regulation of cholesterol transport (GO:0032375) | 3.43576519 |
| 45 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.43063224 |
| 46 | protein maturation by protein folding (GO:0022417) | 3.41528303 |
| 47 | NIK/NF-kappaB signaling (GO:0038061) | 3.41206601 |
| 48 | regulation of fibrinolysis (GO:0051917) | 3.40532103 |
| 49 | cellular response to unfolded protein (GO:0034620) | 3.40401998 |
| 50 | cellular modified amino acid catabolic process (GO:0042219) | 3.38449647 |
| 51 | positive regulation of histone deacetylation (GO:0031065) | 3.37746967 |
| 52 | urea cycle (GO:0000050) | 3.37744212 |
| 53 | urea metabolic process (GO:0019627) | 3.37744212 |
| 54 | ER-nucleus signaling pathway (GO:0006984) | 3.36429946 |
| 55 | complement activation, alternative pathway (GO:0006957) | 3.35908358 |
| 56 | cysteine metabolic process (GO:0006534) | 3.34589204 |
| 57 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.34095946 |
| 58 | activation of Rac GTPase activity (GO:0032863) | 3.30110190 |
| 59 | mannose metabolic process (GO:0006013) | 3.27716720 |
| 60 | pinocytosis (GO:0006907) | 3.27409060 |
| 61 | maternal placenta development (GO:0001893) | 3.24004254 |
| 62 | regulation of protein activation cascade (GO:2000257) | 3.20611324 |
| 63 | cellular response to topologically incorrect protein (GO:0035967) | 3.19864611 |
| 64 | glycine metabolic process (GO:0006544) | 3.17612863 |
| 65 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.16170772 |
| 66 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.15588236 |
| 67 | high-density lipoprotein particle remodeling (GO:0034375) | 3.14355944 |
| 68 | barbed-end actin filament capping (GO:0051016) | 3.12097024 |
| 69 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.11999451 |
| 70 | bile acid biosynthetic process (GO:0006699) | 3.10745942 |
| 71 | cell-substrate adherens junction assembly (GO:0007045) | 3.09657046 |
| 72 | focal adhesion assembly (GO:0048041) | 3.09657046 |
| 73 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.05382317 |
| 74 | homocysteine metabolic process (GO:0050667) | 3.05122132 |
| 75 | regulation of early endosome to late endosome transport (GO:2000641) | 3.03568570 |
| 76 | pentose-phosphate shunt (GO:0006098) | 3.02945613 |
| 77 | indole-containing compound catabolic process (GO:0042436) | 3.02619445 |
| 78 | indolalkylamine catabolic process (GO:0046218) | 3.02619445 |
| 79 | tryptophan catabolic process (GO:0006569) | 3.02619445 |
| 80 | aspartate family amino acid catabolic process (GO:0009068) | 3.02605509 |
| 81 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.02159764 |
| 82 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.02159764 |
| 83 | nitrogen cycle metabolic process (GO:0071941) | 3.01071922 |
| 84 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.00442497 |
| 85 | cellular response to virus (GO:0098586) | 2.99091049 |
| 86 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.99064356 |
| 87 | apoptotic process involved in morphogenesis (GO:0060561) | 2.97360304 |
| 88 | coenzyme catabolic process (GO:0009109) | 2.96887017 |
| 89 | plasma lipoprotein particle clearance (GO:0034381) | 2.94332630 |
| 90 | regulation of integrin activation (GO:0033623) | 2.93596423 |
| 91 | regulation of complement activation (GO:0030449) | 2.93077231 |
| 92 | negative regulation of lipid transport (GO:0032369) | 2.93048001 |
| 93 | phospholipid efflux (GO:0033700) | 2.91514829 |
| 94 | vesicle coating (GO:0006901) | 2.91360487 |
| 95 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.90485159 |
| 96 | negative regulation of viral release from host cell (GO:1902187) | 2.89245593 |
| 97 | stress fiber assembly (GO:0043149) | 2.88955364 |
| 98 | adherens junction assembly (GO:0034333) | 2.88042421 |
| 99 | glutamate metabolic process (GO:0006536) | 2.87913682 |
| 100 | fatty acid homeostasis (GO:0055089) | 2.87701766 |
| 101 | tryptophan metabolic process (GO:0006568) | 2.87575594 |
| 102 | positive regulation of fatty acid oxidation (GO:0046321) | 2.87226458 |
| 103 | cellular ketone body metabolic process (GO:0046950) | 2.85983547 |
| 104 | positive regulation of lipid catabolic process (GO:0050996) | 2.84513604 |
| 105 | regulation of fatty acid oxidation (GO:0046320) | 2.83795344 |
| 106 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.83205265 |
| 107 | skin morphogenesis (GO:0043589) | 2.80919334 |
| 108 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.80461995 |
| 109 | acute-phase response (GO:0006953) | 2.80386439 |
| 110 | negative regulation of fatty acid transport (GO:2000192) | 2.79078476 |
| 111 | one-carbon metabolic process (GO:0006730) | 2.78469610 |
| 112 | response to laminar fluid shear stress (GO:0034616) | 2.75766735 |
| 113 | reverse cholesterol transport (GO:0043691) | 2.74943585 |
| 114 | protein-lipid complex assembly (GO:0065005) | 2.74531181 |
| 115 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.73533637 |
| 116 | phospholipid homeostasis (GO:0055091) | 2.73273798 |
| 117 | desmosome organization (GO:0002934) | 2.72401724 |
| 118 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.72177404 |
| 119 | plasma lipoprotein particle assembly (GO:0034377) | 2.71278678 |
| 120 | regulation of triglyceride catabolic process (GO:0010896) | 2.71145148 |
| 121 | response to endoplasmic reticulum stress (GO:0034976) | 2.70502947 |
| 122 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.69354251 |
| 123 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.69354251 |
| 124 | serine family amino acid catabolic process (GO:0009071) | 2.69189336 |
| 125 | alpha-amino acid catabolic process (GO:1901606) | 2.68003277 |
| 126 | triglyceride homeostasis (GO:0070328) | 2.67781494 |
| 127 | acylglycerol homeostasis (GO:0055090) | 2.67781494 |
| 128 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.67656826 |
| 129 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.67151479 |
| 130 | basement membrane organization (GO:0071711) | 2.65901261 |
| 131 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.64698071 |
| 132 | cell adhesion mediated by integrin (GO:0033627) | 2.63842129 |
| 133 | aromatic amino acid family metabolic process (GO:0009072) | 2.62205025 |
| 134 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.61171443 |
| 135 | modulation by symbiont of host cellular process (GO:0044068) | 2.60726227 |
| 136 | positive regulation of extracellular matrix organization (GO:1903055) | 2.60287322 |
| 137 | membrane protein ectodomain proteolysis (GO:0006509) | 2.55288321 |
| 138 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.53339583 |
| 139 | regulation of somitogenesis (GO:0014807) | 2.52308866 |
| 140 | membrane raft organization (GO:0031579) | 2.51988535 |
| 141 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.51294826 |
| 142 | mammary gland epithelial cell proliferation (GO:0033598) | 2.50648268 |
| 143 | low-density lipoprotein particle clearance (GO:0034383) | 2.50590429 |
| 144 | interferon-gamma secretion (GO:0072643) | 2.49828624 |
| 145 | regulation of extracellular matrix disassembly (GO:0010715) | 2.49076557 |
| 146 | regulation of necroptotic process (GO:0060544) | 2.47937730 |
| 147 | response to peptidoglycan (GO:0032494) | 2.46827760 |
| 148 | response to muramyl dipeptide (GO:0032495) | 2.44534628 |
| 149 | semaphorin-plexin signaling pathway (GO:0071526) | 2.44138693 |
| 150 | germinal center formation (GO:0002467) | 2.40828633 |
| 151 | hyaluronan catabolic process (GO:0030214) | 2.39669374 |
| 152 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.35223886 |
| 153 | negative regulation of necroptotic process (GO:0060546) | 2.35209435 |
| 154 | hypotonic response (GO:0006971) | 2.32744503 |
| 155 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.31413542 |
| 156 | trophoblast giant cell differentiation (GO:0060707) | 2.30846621 |
| 157 | regulation of superoxide anion generation (GO:0032928) | 2.30053796 |
| 158 | regulation of leukocyte degranulation (GO:0043300) | 2.29280640 |
| 159 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.29199743 |
| 160 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.27837895 |
| 161 | UV protection (GO:0009650) | 2.27560498 |
| 162 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.27272065 |
| 163 | embryonic process involved in female pregnancy (GO:0060136) | 2.26512343 |
| 164 | adhesion of symbiont to host (GO:0044406) | 2.25648749 |
| 165 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.24226044 |
| 166 | apoptotic cell clearance (GO:0043277) | 2.23646483 |
| 167 | activation of MAPKKK activity (GO:0000185) | 2.22697690 |
| 168 | regulation of translational termination (GO:0006449) | 2.22299141 |
| 169 | cellular response to arsenic-containing substance (GO:0071243) | 2.22134701 |
| 170 | substrate-dependent cell migration (GO:0006929) | 2.21792935 |
| 171 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.20780944 |
| 172 | positive regulation of protein dephosphorylation (GO:0035307) | 2.19647379 |
| 173 | cellular response to nutrient (GO:0031670) | 2.18857792 |
| 174 | endodermal cell differentiation (GO:0035987) | 2.18741841 |
| 175 | cellular response to exogenous dsRNA (GO:0071360) | 2.18137077 |
| 176 | regulation of necrotic cell death (GO:0010939) | 2.16766416 |
| 177 | decidualization (GO:0046697) | 2.16591651 |
| 178 | modulation by virus of host process (GO:0019054) | 2.16192009 |
| 179 | endothelial cell chemotaxis (GO:0035767) | 2.15599484 |
| 180 | positive regulation by symbiont of host defense response (GO:0052509) | 2.14377446 |
| 181 | modulation by symbiont of host defense response (GO:0052031) | 2.14377446 |
| 182 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.14377446 |
| 183 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.14377446 |
| 184 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.14377446 |
| 185 | modulation by symbiont of host immune response (GO:0052553) | 2.14377446 |
| 186 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.14207185 |
| 187 | regulation of histone H3-K27 methylation (GO:0061085) | 2.13456622 |
| 188 | positive regulation of protein deacetylation (GO:0090312) | 2.13031428 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.64312228 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.96960255 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.79864401 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.68644110 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 3.19659787 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.13397518 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.99958119 |
| 8 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.97519522 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.87380334 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.61964686 |
| 11 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.54683767 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.49321755 |
| 13 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.28358209 |
| 14 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.25722487 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.12842539 |
| 16 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.12368236 |
| 17 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.09590084 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.07626387 |
| 19 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.07035076 |
| 20 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.02631215 |
| 21 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.02441065 |
| 22 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.02372496 |
| 23 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.97247286 |
| 24 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.89694043 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.86449971 |
| 26 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.79069216 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.78418616 |
| 28 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.74659446 |
| 29 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.66986571 |
| 30 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.66907081 |
| 31 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.65991927 |
| 32 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.64187554 |
| 33 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.62516725 |
| 34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.62333282 |
| 35 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.59775105 |
| 36 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.56341142 |
| 37 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.54110158 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 1.53709588 |
| 39 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.48647694 |
| 40 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.47536776 |
| 41 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.44674284 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.42374312 |
| 43 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.41058867 |
| 44 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.40332017 |
| 45 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.37270100 |
| 46 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.36669763 |
| 47 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.34925281 |
| 48 | ATF3_27146783_Chip-Seq_COLON_Human | 1.34820662 |
| 49 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.34681160 |
| 50 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.34592164 |
| 51 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.33021136 |
| 52 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.32732077 |
| 53 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.32255444 |
| 54 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.31723782 |
| 55 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.30638984 |
| 56 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.30568331 |
| 57 | P68_20966046_ChIP-Seq_HELA_Human | 1.28910413 |
| 58 | KDM2B_26808549_Chip-Seq_K562_Human | 1.27979538 |
| 59 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.27557724 |
| 60 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.27036321 |
| 61 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26454266 |
| 62 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.23825782 |
| 63 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.23255794 |
| 64 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.22749896 |
| 65 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.22500583 |
| 66 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.22465981 |
| 67 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21993714 |
| 68 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.21904917 |
| 69 | GATA1_22025678_ChIP-Seq_K562_Human | 1.20925521 |
| 70 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.19158544 |
| 71 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.18776409 |
| 72 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.18288883 |
| 73 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.18013156 |
| 74 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.17874118 |
| 75 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.17034631 |
| 76 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14161089 |
| 77 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.13986489 |
| 78 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.13315138 |
| 79 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11482550 |
| 80 | SPI1_23127762_ChIP-Seq_K562_Human | 1.11336637 |
| 81 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.11283666 |
| 82 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.10069529 |
| 83 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.08824472 |
| 84 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08599927 |
| 85 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08194438 |
| 86 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.08118632 |
| 87 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.07915084 |
| 88 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.07891201 |
| 89 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.07891201 |
| 90 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.07754841 |
| 91 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.07603081 |
| 92 | MAF_26560356_Chip-Seq_TH2_Human | 1.07571299 |
| 93 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.07570398 |
| 94 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07542661 |
| 95 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.06993714 |
| 96 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06328254 |
| 97 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.06320443 |
| 98 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06198877 |
| 99 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.05908587 |
| 100 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.05847013 |
| 101 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.05461634 |
| 102 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04811975 |
| 103 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.04736842 |
| 104 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.04658474 |
| 105 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03999016 |
| 106 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.03981014 |
| 107 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.03551008 |
| 108 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.02893870 |
| 109 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.02797097 |
| 110 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.01430134 |
| 111 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.01167145 |
| 112 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.00403407 |
| 113 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.00389251 |
| 114 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.00308873 |
| 115 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.00206822 |
| 116 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.98730142 |
| 117 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97324895 |
| 118 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.97061565 |
| 119 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.96601285 |
| 120 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96562718 |
| 121 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.96495506 |
| 122 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.96495506 |
| 123 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.95987036 |
| 124 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95475469 |
| 125 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95032434 |
| 126 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95013964 |
| 127 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.94794576 |
| 128 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.94633329 |
| 129 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94174821 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.67415162 |
| 2 | MP0005360_urolithiasis | 3.74965057 |
| 3 | MP0005365_abnormal_bile_salt | 3.72154256 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.68210239 |
| 5 | MP0005083_abnormal_biliary_tract | 3.63406025 |
| 6 | MP0005451_abnormal_body_composition | 3.47153449 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 3.44559066 |
| 8 | MP0009840_abnormal_foam_cell | 3.30125127 |
| 9 | MP0002837_dystrophic_cardiac_calcinosis | 2.90069614 |
| 10 | MP0003252_abnormal_bile_duct | 2.56759568 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.32443712 |
| 12 | MP0002909_abnormal_adrenal_gland | 2.28881829 |
| 13 | MP0008961_abnormal_basal_metabolism | 2.22877852 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.13505789 |
| 15 | MP0002877_abnormal_melanocyte_morpholog | 2.11680503 |
| 16 | MP0003806_abnormal_nucleotide_metabolis | 2.11344309 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.02032188 |
| 18 | MP0005220_abnormal_exocrine_pancreas | 1.99478772 |
| 19 | MP0008875_abnormal_xenobiotic_pharmacok | 1.98438527 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 1.96904244 |
| 21 | MP0003303_peritoneal_inflammation | 1.92803244 |
| 22 | MP0005076_abnormal_cell_differentiation | 1.91131071 |
| 23 | MP0003195_calcinosis | 1.89609983 |
| 24 | MP0003283_abnormal_digestive_organ | 1.85609452 |
| 25 | MP0003453_abnormal_keratinocyte_physiol | 1.80323832 |
| 26 | MP0001944_abnormal_pancreas_morphology | 1.77908221 |
| 27 | MP0000609_abnormal_liver_physiology | 1.77086384 |
| 28 | MP0003436_decreased_susceptibility_to | 1.71169617 |
| 29 | MP0003172_abnormal_lysosome_physiology | 1.65160144 |
| 30 | MP0004272_abnormal_basement_membrane | 1.64452473 |
| 31 | MP0008260_abnormal_autophagy | 1.63356449 |
| 32 | MP0002693_abnormal_pancreas_physiology | 1.63323244 |
| 33 | MP0005257_abnormal_intraocular_pressure | 1.56840133 |
| 34 | MP0002118_abnormal_lipid_homeostasis | 1.54273857 |
| 35 | MP0000858_altered_metastatic_potential | 1.54193233 |
| 36 | MP0005409_darkened_coat_color | 1.53383571 |
| 37 | MP0002078_abnormal_glucose_homeostasis | 1.52901623 |
| 38 | MP0003329_amyloid_beta_deposits | 1.49652086 |
| 39 | MP0002060_abnormal_skin_morphology | 1.48103985 |
| 40 | MP0009780_abnormal_chondrocyte_physiolo | 1.47028181 |
| 41 | MP0000733_abnormal_muscle_development | 1.42775447 |
| 42 | MP0003183_abnormal_peptide_metabolism | 1.37719280 |
| 43 | MP0003950_abnormal_plasma_membrane | 1.35498774 |
| 44 | MP0000003_abnormal_adipose_tissue | 1.34922693 |
| 45 | MP0005332_abnormal_amino_acid | 1.34873028 |
| 46 | MP0005319_abnormal_enzyme/_coenzyme | 1.33030866 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.32366855 |
| 48 | MP0005058_abnormal_lysosome_morphology | 1.32127129 |
| 49 | MP0001348_abnormal_lacrimal_gland | 1.32103167 |
| 50 | MP0000604_amyloidosis | 1.31395839 |
| 51 | MP0004130_abnormal_muscle_cell | 1.29767564 |
| 52 | MP0003868_abnormal_feces_composition | 1.28222486 |
| 53 | MP0000013_abnormal_adipose_tissue | 1.27658744 |
| 54 | MP0002269_muscular_atrophy | 1.27282644 |
| 55 | MP0004510_myositis | 1.26366742 |
| 56 | MP0006054_spinal_hemorrhage | 1.25948116 |
| 57 | MP0004858_abnormal_nervous_system | 1.25366214 |
| 58 | MP0004185_abnormal_adipocyte_glucose | 1.24898565 |
| 59 | MP0001958_emphysema | 1.23099248 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.22115823 |
| 61 | MP0002138_abnormal_hepatobiliary_system | 1.20154080 |
| 62 | MP0008438_abnormal_cutaneous_collagen | 1.20080327 |
| 63 | MP0010234_abnormal_vibrissa_follicle | 1.18912563 |
| 64 | MP0002419_abnormal_innate_immunity | 1.18821698 |
| 65 | MP0001216_abnormal_epidermal_layer | 1.14964326 |
| 66 | MP0000598_abnormal_liver_morphology | 1.14899491 |
| 67 | MP0010368_abnormal_lymphatic_system | 1.14699546 |
| 68 | MP0009643_abnormal_urine_homeostasis | 1.12394659 |
| 69 | MP0003828_pulmonary_edema | 1.12158248 |
| 70 | MP0003763_abnormal_thymus_physiology | 1.12087578 |
| 71 | MP0010352_gastrointestinal_tract_polyps | 1.11806192 |
| 72 | MP0000750_abnormal_muscle_regeneration | 1.10171775 |
| 73 | MP0005025_abnormal_response_to | 1.08984821 |
| 74 | MP0005000_abnormal_immune_tolerance | 1.08668301 |
| 75 | MP0002796_impaired_skin_barrier | 1.07922529 |
| 76 | MP0002089_abnormal_postnatal_growth/wei | 1.07402928 |
| 77 | MP0005375_adipose_tissue_phenotype | 1.06545970 |
| 78 | MP0003959_abnormal_lean_body | 1.06304067 |
| 79 | MP0003566_abnormal_cell_adhesion | 1.06300317 |
| 80 | MP0000767_abnormal_smooth_muscle | 1.05515694 |
| 81 | MP0000751_myopathy | 1.04775173 |
| 82 | MP0002452_abnormal_antigen_presenting | 1.04318471 |
| 83 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.02481656 |
| 84 | MP0005501_abnormal_skin_physiology | 1.02402282 |
| 85 | MP0004087_abnormal_muscle_fiber | 1.01378532 |
| 86 | MP0000685_abnormal_immune_system | 1.00309866 |
| 87 | MP0001835_abnormal_antigen_presentation | 0.98918923 |
| 88 | MP0002332_abnormal_exercise_endurance | 0.98101175 |
| 89 | MP0002928_abnormal_bile_duct | 0.95932325 |
| 90 | MP0002148_abnormal_hypersensitivity_rea | 0.95679998 |
| 91 | MP0002723_abnormal_immune_serum | 0.93961779 |
| 92 | MP0000678_abnormal_parathyroid_gland | 0.93497562 |
| 93 | MP0004233_abnormal_muscle_weight | 0.92148596 |
| 94 | MP0000467_abnormal_esophagus_morphology | 0.92139347 |
| 95 | MP0000343_altered_response_to | 0.91805496 |
| 96 | MP0001800_abnormal_humoral_immune | 0.91727750 |
| 97 | MP0002396_abnormal_hematopoietic_system | 0.91101847 |
| 98 | MP0001853_heart_inflammation | 0.89740199 |
| 99 | MP0010155_abnormal_intestine_physiology | 0.88569347 |
| 100 | MP0005023_abnormal_wound_healing | 0.88512204 |
| 101 | MP0001819_abnormal_immune_cell | 0.87157768 |
| 102 | MP0003075_altered_response_to | 0.86982794 |
| 103 | MP0002420_abnormal_adaptive_immunity | 0.86962895 |
| 104 | MP0001873_stomach_inflammation | 0.86524074 |
| 105 | MP0004808_abnormal_hematopoietic_stem | 0.85373953 |
| 106 | MP0002970_abnormal_white_adipose | 0.84333819 |
| 107 | MP0005621_abnormal_cell_physiology | 0.83391584 |
| 108 | MP0002933_joint_inflammation | 0.83130617 |
| 109 | MP0000747_muscle_weakness | 0.82786978 |
| 110 | MP0005666_abnormal_adipose_tissue | 0.82198888 |
| 111 | MP0005448_abnormal_energy_balance | 0.82048246 |
| 112 | MP0002405_respiratory_system_inflammati | 0.81890620 |
| 113 | MP0008469_abnormal_protein_level | 0.81124696 |
| 114 | MP0001243_abnormal_dermal_layer | 0.80312073 |
| 115 | MP0002234_abnormal_pharynx_morphology | 0.80264598 |
| 116 | MP0009672_abnormal_birth_weight | 0.80141080 |
| 117 | MP0009642_abnormal_blood_homeostasis | 0.80100911 |
| 118 | MP0009931_abnormal_skin_appearance | 0.79877624 |
| 119 | MP0005670_abnormal_white_adipose | 0.77741268 |
| 120 | MP0010630_abnormal_cardiac_muscle | 0.77497019 |
| 121 | MP0000759_abnormal_skeletal_muscle | 0.77201391 |
| 122 | MP0003656_abnormal_erythrocyte_physiolo | 0.77097443 |
| 123 | MP0003279_aneurysm | 0.77061603 |
| 124 | MP0005390_skeleton_phenotype | 0.76013689 |
| 125 | MP0009785_altered_susceptibility_to | 0.75868204 |
| 126 | MP0003448_altered_tumor_morphology | 0.75208924 |
| 127 | MP0005671_abnormal_response_to | 0.75085033 |
| 128 | MP0004947_skin_inflammation | 0.74941680 |
| 129 | MP0006036_abnormal_mitochondrial_physio | 0.72004354 |
| 130 | MP0005535_abnormal_body_temperature | 0.69326484 |
| 131 | MP0002971_abnormal_brown_adipose | 0.68940723 |
| 132 | MP0005330_cardiomyopathy | 0.68003071 |
| 133 | MP0000749_muscle_degeneration | 0.67419258 |
| 134 | MP0005464_abnormal_platelet_physiology | 0.66571609 |
| 135 | MP0004782_abnormal_surfactant_physiolog | 0.66091381 |
| 136 | MP0001533_abnormal_skeleton_physiology | 0.65653589 |
| 137 | MP0004264_abnormal_extraembryonic_tissu | 0.64944545 |
| 138 | MP0001790_abnormal_immune_system | 0.63885999 |
| 139 | MP0005387_immune_system_phenotype | 0.63885999 |
| 140 | MP0009278_abnormal_bone_marrow | 0.63168795 |
| 141 | MP0005334_abnormal_fat_pad | 0.61196316 |
| 142 | MP0003953_abnormal_hormone_level | 0.60912700 |
| 143 | MP0001845_abnormal_inflammatory_respons | 0.60680193 |
| 144 | MP0003091_abnormal_cell_migration | 0.60270247 |
| 145 | MP0004036_abnormal_muscle_relaxation | 0.60103623 |
| 146 | MP0001849_ear_inflammation | 0.58561859 |
| 147 | MP0009763_increased_sensitivity_to | 0.58391761 |
| 148 | MP0000358_abnormal_cell_content/ | 0.57711181 |
| 149 | MP0005636_abnormal_mineral_homeostasis | 0.57538974 |
| 150 | MP0001765_abnormal_ion_homeostasis | 0.56805585 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.57403510 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.86349571 |
| 3 | Hypoglycemic coma (HP:0001325) | 3.70469373 |
| 4 | Xanthomatosis (HP:0000991) | 3.69207044 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.59942843 |
| 6 | Abnormality of the common coagulation pathway (HP:0010990) | 3.54645070 |
| 7 | Late onset (HP:0003584) | 3.45615056 |
| 8 | Ketoacidosis (HP:0001993) | 3.44042517 |
| 9 | Distal lower limb amyotrophy (HP:0008944) | 3.38642376 |
| 10 | Intrahepatic cholestasis (HP:0001406) | 3.35370177 |
| 11 | Abnormality of the intrinsic pathway (HP:0010989) | 3.33412253 |
| 12 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.29307389 |
| 13 | Ketosis (HP:0001946) | 3.26736850 |
| 14 | Premature rupture of membranes (HP:0001788) | 3.12401780 |
| 15 | Hypoglycemic seizures (HP:0002173) | 3.09269616 |
| 16 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.08834583 |
| 17 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.08834583 |
| 18 | Abnormality of glycolipid metabolism (HP:0010969) | 3.08834583 |
| 19 | Vertebral compression fractures (HP:0002953) | 3.07816921 |
| 20 | Distal lower limb muscle weakness (HP:0009053) | 3.05142045 |
| 21 | Broad face (HP:0000283) | 2.92250102 |
| 22 | Prolonged partial thromboplastin time (HP:0003645) | 2.89978951 |
| 23 | Complement deficiency (HP:0004431) | 2.82220038 |
| 24 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.80429160 |
| 25 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.80429160 |
| 26 | Skin nodule (HP:0200036) | 2.73826929 |
| 27 | Joint hemorrhage (HP:0005261) | 2.67834335 |
| 28 | Hyperlipoproteinemia (HP:0010980) | 2.62387095 |
| 29 | J-shaped sella turcica (HP:0002680) | 2.56816571 |
| 30 | Hypobetalipoproteinemia (HP:0003563) | 2.56027923 |
| 31 | Mucopolysacchariduria (HP:0008155) | 2.54894140 |
| 32 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.54894140 |
| 33 | Cerebral aneurysm (HP:0004944) | 2.52491590 |
| 34 | Myoglobinuria (HP:0002913) | 2.48528018 |
| 35 | Protrusio acetabuli (HP:0003179) | 2.45744719 |
| 36 | Gout (HP:0001997) | 2.45243657 |
| 37 | Rough bone trabeculation (HP:0100670) | 2.42855900 |
| 38 | Flat acetabular roof (HP:0003180) | 2.41211492 |
| 39 | Abnormality of complement system (HP:0005339) | 2.38459101 |
| 40 | Abnormality of the Achilles tendon (HP:0005109) | 2.38093416 |
| 41 | Fragile skin (HP:0001030) | 2.36185779 |
| 42 | Peritonitis (HP:0002586) | 2.35717453 |
| 43 | Interstitial pulmonary disease (HP:0006530) | 2.35066966 |
| 44 | Long toe (HP:0010511) | 2.33888199 |
| 45 | Spinal rigidity (HP:0003306) | 2.33705121 |
| 46 | Cervical subluxation (HP:0003308) | 2.32766231 |
| 47 | Back pain (HP:0003418) | 2.32373077 |
| 48 | Milia (HP:0001056) | 2.32091351 |
| 49 | Asymmetric septal hypertrophy (HP:0001670) | 2.31545001 |
| 50 | Atrophic scars (HP:0001075) | 2.31110088 |
| 51 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.29712526 |
| 52 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.29712526 |
| 53 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.29712526 |
| 54 | Lower limb amyotrophy (HP:0007210) | 2.27920797 |
| 55 | Upper limb amyotrophy (HP:0009129) | 2.27577093 |
| 56 | Distal upper limb amyotrophy (HP:0007149) | 2.27577093 |
| 57 | Hyperammonemia (HP:0001987) | 2.27314640 |
| 58 | Mitral stenosis (HP:0001718) | 2.27144771 |
| 59 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.25103129 |
| 60 | Generalized amyotrophy (HP:0003700) | 2.23449172 |
| 61 | Hand muscle atrophy (HP:0009130) | 2.22211314 |
| 62 | Dysostosis multiplex (HP:0000943) | 2.21994534 |
| 63 | Myocardial infarction (HP:0001658) | 2.21041084 |
| 64 | Obstructive sleep apnea (HP:0002870) | 2.18168782 |
| 65 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.17176236 |
| 66 | Hypercortisolism (HP:0001578) | 2.14636078 |
| 67 | Short nail (HP:0001799) | 2.14198583 |
| 68 | Increased variability in muscle fiber diameter (HP:0003557) | 2.14075625 |
| 69 | Abnormal gallbladder morphology (HP:0012437) | 2.13761337 |
| 70 | Achilles tendon contracture (HP:0001771) | 2.13255152 |
| 71 | Aortic regurgitation (HP:0001659) | 2.12892456 |
| 72 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.11417022 |
| 73 | Symptomatic seizures (HP:0011145) | 2.10713523 |
| 74 | Axonal loss (HP:0003447) | 2.10511411 |
| 75 | Hyperglycemia (HP:0003074) | 2.09793856 |
| 76 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.09255168 |
| 77 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.09095003 |
| 78 | Aneurysm (HP:0002617) | 2.07727117 |
| 79 | Global brain atrophy (HP:0002283) | 2.06531250 |
| 80 | Cholelithiasis (HP:0001081) | 2.05893575 |
| 81 | Hypolipoproteinemia (HP:0010981) | 2.05717406 |
| 82 | Type 1 muscle fiber predominance (HP:0003803) | 2.05590494 |
| 83 | Oral leukoplakia (HP:0002745) | 2.04594345 |
| 84 | Ankle contracture (HP:0006466) | 2.03420631 |
| 85 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.02433655 |
| 86 | Lymphangioma (HP:0100764) | 2.02173493 |
| 87 | Spastic diplegia (HP:0001264) | 2.02051217 |
| 88 | Hypoalphalipoproteinemia (HP:0003233) | 2.00932225 |
| 89 | Deformed sella turcica (HP:0002681) | 2.00257430 |
| 90 | Hyperbilirubinemia (HP:0002904) | 2.00046440 |
| 91 | Abnormality of the thoracic spine (HP:0100711) | 2.00040383 |
| 92 | Elbow flexion contracture (HP:0002987) | 1.98768526 |
| 93 | Natal tooth (HP:0000695) | 1.98544868 |
| 94 | Ulnar bowing (HP:0003031) | 1.98296013 |
| 95 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.98243863 |
| 96 | Increased cerebral lipofuscin (HP:0011813) | 1.97251041 |
| 97 | Epidermoid cyst (HP:0200040) | 1.96575475 |
| 98 | Death in childhood (HP:0003819) | 1.96066677 |
| 99 | Polycythemia (HP:0001901) | 1.95634162 |
| 100 | Osteolytic defects of the hand bones (HP:0009699) | 1.95503701 |
| 101 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.95503701 |
| 102 | Hemorrhage of the eye (HP:0011885) | 1.94969031 |
| 103 | Pathologic fracture (HP:0002756) | 1.94356554 |
| 104 | Large for gestational age (HP:0001520) | 1.93771114 |
| 105 | Thoracic kyphosis (HP:0002942) | 1.91777585 |
| 106 | Persistence of primary teeth (HP:0006335) | 1.91367712 |
| 107 | Insulin resistance (HP:0000855) | 1.91235365 |
| 108 | Hyperacusis (HP:0010780) | 1.90060189 |
| 109 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.89421211 |
| 110 | Progressive muscle weakness (HP:0003323) | 1.88948249 |
| 111 | Abnormal trabecular bone morphology (HP:0100671) | 1.88692554 |
| 112 | Abnormality of purine metabolism (HP:0004352) | 1.86902523 |
| 113 | Reticulocytosis (HP:0001923) | 1.86508840 |
| 114 | Abnormality of the lower motor neuron (HP:0002366) | 1.85313394 |
| 115 | Mitral regurgitation (HP:0001653) | 1.84940143 |
| 116 | Insomnia (HP:0100785) | 1.84361871 |
| 117 | Abnormality of the odontoid process (HP:0003310) | 1.83306623 |
| 118 | Fat malabsorption (HP:0002630) | 1.83285382 |
| 119 | Neonatal onset (HP:0003623) | 1.83067383 |
| 120 | Multiple lipomas (HP:0001012) | 1.82812900 |
| 121 | Increased serum ferritin (HP:0003281) | 1.81990167 |
| 122 | Ridged nail (HP:0001807) | 1.81443276 |
| 123 | Upper motor neuron abnormality (HP:0002127) | 1.80642927 |
| 124 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.80064042 |
| 125 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.79759252 |
| 126 | Shallow orbits (HP:0000586) | 1.79708392 |
| 127 | Increased connective tissue (HP:0009025) | 1.78987168 |
| 128 | Thick nail (HP:0001805) | 1.77562653 |
| 129 | Joint stiffness (HP:0001387) | 1.75702197 |
| 130 | Thoracolumbar scoliosis (HP:0002944) | 1.75252534 |
| 131 | Protuberant abdomen (HP:0001538) | 1.75092582 |
| 132 | Limb-girdle muscle atrophy (HP:0003797) | 1.74861023 |
| 133 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.74768011 |
| 134 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.73753279 |
| 135 | Tachypnea (HP:0002789) | 1.73676641 |
| 136 | Spondylolisthesis (HP:0003302) | 1.73272677 |
| 137 | Sudden death (HP:0001699) | 1.72787071 |
| 138 | Nail dystrophy (HP:0008404) | 1.72593074 |
| 139 | Short femoral neck (HP:0100864) | 1.72196978 |
| 140 | Arterial tortuosity (HP:0005116) | 1.70348257 |
| 141 | Trismus (HP:0000211) | 1.68940820 |
| 142 | Abnormality of nucleobase metabolism (HP:0010932) | 1.68846438 |
| 143 | Papilledema (HP:0001085) | 1.68771679 |
| 144 | Wormian bones (HP:0002645) | 1.67863268 |
| 145 | Bladder diverticulum (HP:0000015) | 1.67780411 |
| 146 | Agitation (HP:0000713) | 1.67567754 |
| 147 | Abnormality of macrophages (HP:0004311) | 1.67009472 |
| 148 | Esophageal varix (HP:0002040) | 1.67000190 |
| 149 | Nuclear cataract (HP:0100018) | 1.66458438 |
| 150 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.65492535 |
| 151 | Blue sclerae (HP:0000592) | 1.65364470 |
| 152 | Myopathic facies (HP:0002058) | 1.64989853 |
| 153 | Vascular tortuosity (HP:0004948) | 1.64373418 |
| 154 | Bowing of the arm (HP:0006488) | 1.63715726 |
| 155 | Bowed forearm bones (HP:0003956) | 1.63715726 |
| 156 | Spinal cord lesions (HP:0100561) | 1.63664390 |
| 157 | Syringomyelia (HP:0003396) | 1.63664390 |
| 158 | Dilatation of the ascending aorta (HP:0005111) | 1.63532678 |
| 159 | Ragged-red muscle fibers (HP:0003200) | 1.62942820 |
| 160 | Eczematoid dermatitis (HP:0000976) | 1.62828478 |
| 161 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.62490716 |
| 162 | Abnormal ossification of hand bones (HP:0005921) | 1.62460116 |
| 163 | Neoplasm of the heart (HP:0100544) | 1.62177922 |
| 164 | Polygenic inheritance (HP:0010982) | 1.62090833 |
| 165 | Mitral valve prolapse (HP:0001634) | 1.61977682 |
| 166 | Difficulty climbing stairs (HP:0003551) | 1.61907184 |
| 167 | Thin bony cortex (HP:0002753) | 1.61333539 |
| 168 | Disproportionate tall stature (HP:0001519) | 1.60993458 |
| 169 | Striae distensae (HP:0001065) | 1.60539746 |
| 170 | Athetosis (HP:0002305) | 1.60182257 |
| 171 | Abnormality of the gallbladder (HP:0005264) | 1.60154980 |
| 172 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.60043992 |
| 173 | Exercise-induced myalgia (HP:0003738) | 1.58800773 |
| 174 | Hamartoma of the eye (HP:0010568) | 1.58551847 |
| 175 | Ventricular tachycardia (HP:0004756) | 1.58551530 |
| 176 | Cerebral inclusion bodies (HP:0100314) | 1.57434015 |
| 177 | Menorrhagia (HP:0000132) | 1.57256582 |
| 178 | Turricephaly (HP:0000262) | 1.56304793 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 5.57017539 |
| 2 | ERN1 | 5.13710958 |
| 3 | PKN2 | 4.38361416 |
| 4 | IRAK3 | 3.48201876 |
| 5 | PRPF4B | 2.97010207 |
| 6 | EEF2K | 2.96703404 |
| 7 | SMG1 | 2.95121035 |
| 8 | NME2 | 2.56607346 |
| 9 | BCKDK | 2.56001064 |
| 10 | MAP3K10 | 2.46147743 |
| 11 | EPHA2 | 2.40062194 |
| 12 | TTN | 2.30071794 |
| 13 | MST1R | 2.25755549 |
| 14 | BLK | 2.18975603 |
| 15 | PTK6 | 2.09028778 |
| 16 | SIK1 | 1.99551438 |
| 17 | MAP4K1 | 1.95071947 |
| 18 | TAOK3 | 1.93087179 |
| 19 | FGFR4 | 1.73436235 |
| 20 | PASK | 1.65893527 |
| 21 | PDGFRA | 1.64499121 |
| 22 | FLT3 | 1.59024756 |
| 23 | TAOK2 | 1.48635327 |
| 24 | RIPK1 | 1.45815361 |
| 25 | TYK2 | 1.44141969 |
| 26 | SCYL2 | 1.42360337 |
| 27 | PRKD3 | 1.41241179 |
| 28 | HIPK2 | 1.34005129 |
| 29 | GRK6 | 1.32247026 |
| 30 | MAP3K14 | 1.28687783 |
| 31 | MAP3K3 | 1.28622727 |
| 32 | TBK1 | 1.25276984 |
| 33 | INSRR | 1.22334565 |
| 34 | CDK12 | 1.19834081 |
| 35 | MAPKAPK3 | 1.18266844 |
| 36 | PIM2 | 1.16287561 |
| 37 | TESK1 | 1.15342168 |
| 38 | PRKCH | 1.14274370 |
| 39 | RET | 1.13009376 |
| 40 | LIMK1 | 1.10655945 |
| 41 | ZAP70 | 1.08958624 |
| 42 | LRRK2 | 1.06375474 |
| 43 | TAOK1 | 1.05911021 |
| 44 | MOS | 1.05509496 |
| 45 | MAP3K1 | 1.03553665 |
| 46 | MAP3K13 | 1.03161791 |
| 47 | KSR2 | 1.03061347 |
| 48 | MAP2K3 | 1.01340092 |
| 49 | NEK9 | 1.00930500 |
| 50 | TGFBR2 | 1.00031122 |
| 51 | ALK | 0.99848334 |
| 52 | IRAK4 | 0.99642865 |
| 53 | BMX | 0.97805952 |
| 54 | MTOR | 0.96786190 |
| 55 | ICK | 0.95459998 |
| 56 | CAMKK1 | 0.91584445 |
| 57 | JAK2 | 0.91544731 |
| 58 | MET | 0.91388956 |
| 59 | PTK2 | 0.90890413 |
| 60 | SIK2 | 0.90434275 |
| 61 | MAP3K11 | 0.89456686 |
| 62 | MAP3K7 | 0.88745574 |
| 63 | MAPK15 | 0.88686497 |
| 64 | TLK1 | 0.87875088 |
| 65 | ARAF | 0.87178463 |
| 66 | JAK3 | 0.84807411 |
| 67 | UHMK1 | 0.84583309 |
| 68 | NTRK1 | 0.81777812 |
| 69 | JAK1 | 0.80024067 |
| 70 | KDR | 0.78959383 |
| 71 | MAP3K2 | 0.76662917 |
| 72 | RPS6KA2 | 0.74612557 |
| 73 | DAPK2 | 0.74396408 |
| 74 | MAPK11 | 0.74258931 |
| 75 | NEK1 | 0.72182956 |
| 76 | LATS2 | 0.70723355 |
| 77 | MELK | 0.69907563 |
| 78 | DYRK1B | 0.69421145 |
| 79 | DAPK1 | 0.63713696 |
| 80 | MAP2K2 | 0.60993442 |
| 81 | EPHB1 | 0.60725238 |
| 82 | MAP3K6 | 0.60722916 |
| 83 | CDK8 | 0.60710744 |
| 84 | TRPM7 | 0.60467910 |
| 85 | MARK2 | 0.60036902 |
| 86 | MAPK12 | 0.59705740 |
| 87 | DDR2 | 0.58621005 |
| 88 | CDK9 | 0.55965698 |
| 89 | RPS6KA4 | 0.55758437 |
| 90 | PAK4 | 0.54071169 |
| 91 | MAPK7 | 0.53748271 |
| 92 | WNK3 | 0.53379866 |
| 93 | MAPKAPK2 | 0.53174822 |
| 94 | PRKD1 | 0.52721712 |
| 95 | CDC42BPA | 0.52330415 |
| 96 | SIK3 | 0.52060390 |
| 97 | IKBKB | 0.51603561 |
| 98 | BRSK1 | 0.51065512 |
| 99 | ERBB4 | 0.50973171 |
| 100 | PAK6 | 0.50106454 |
| 101 | MAP3K8 | 0.50063698 |
| 102 | MAP2K4 | 0.49970008 |
| 103 | CAMK1G | 0.49598224 |
| 104 | PDPK1 | 0.49567346 |
| 105 | AURKA | 0.49217613 |
| 106 | PRKD2 | 0.48669892 |
| 107 | RPS6KL1 | 0.47430369 |
| 108 | RPS6KC1 | 0.47430369 |
| 109 | BRAF | 0.47269338 |
| 110 | PDGFRB | 0.46317370 |
| 111 | RPS6KA6 | 0.45100948 |
| 112 | BTK | 0.45084943 |
| 113 | STK10 | 0.44483538 |
| 114 | ITK | 0.43820478 |
| 115 | SYK | 0.42832895 |
| 116 | CDK7 | 0.42421943 |
| 117 | PAK2 | 0.42407671 |
| 118 | CSK | 0.41549357 |
| 119 | GRK7 | 0.41429439 |
| 120 | CDK6 | 0.40592131 |
| 121 | RIPK4 | 0.40239567 |
| 122 | PDK1 | 0.40164356 |
| 123 | PRKG2 | 0.39885188 |
| 124 | CLK1 | 0.39793371 |
| 125 | LMTK2 | 0.39708236 |
| 126 | EPHB2 | 0.39639457 |
| 127 | CHUK | 0.39492012 |
| 128 | ILK | 0.39387576 |
| 129 | DAPK3 | 0.38698320 |
| 130 | ABL2 | 0.38591561 |
| 131 | HCK | 0.38482764 |
| 132 | RPS6KA1 | 0.37037130 |
| 133 | CDK4 | 0.35192521 |
| 134 | CAMK1D | 0.34929967 |
| 135 | FES | 0.32442569 |
| 136 | CSF1R | 0.31512985 |
| 137 | NEK2 | 0.30750839 |
| 138 | EGFR | 0.29919828 |
| 139 | PIK3CG | 0.29667213 |
| 140 | MAP2K1 | 0.29464445 |
| 141 | PAK3 | 0.27931578 |
| 142 | TESK2 | 0.27738155 |
| 143 | ERBB2 | 0.27569175 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.55482355 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.63848200 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.16290852 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.98564417 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.94016422 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.43620091 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.43484107 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.39881597 |
| 9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.38105773 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.35365409 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.18460622 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.12091008 |
| 13 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.98332091 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.96067943 |
| 15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.86379536 |
| 16 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.60929123 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.57288067 |
| 18 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.56005155 |
| 19 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.51496118 |
| 20 | Carbon metabolism_Homo sapiens_hsa01200 | 1.50843689 |
| 21 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.48574847 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.48274954 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.47193376 |
| 24 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.46319250 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.45371341 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.41528981 |
| 27 | Insulin resistance_Homo sapiens_hsa04931 | 1.40346576 |
| 28 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.39808463 |
| 29 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.39294145 |
| 30 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.36878264 |
| 31 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.33869665 |
| 32 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.33403516 |
| 33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.33339204 |
| 34 | Apoptosis_Homo sapiens_hsa04210 | 1.33104681 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.33088576 |
| 36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.29582443 |
| 37 | Lysine degradation_Homo sapiens_hsa00310 | 1.29132861 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.28938557 |
| 39 | Focal adhesion_Homo sapiens_hsa04510 | 1.27210691 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.21681475 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 1.21675218 |
| 42 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.21490908 |
| 43 | Shigellosis_Homo sapiens_hsa05131 | 1.18615489 |
| 44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.18357520 |
| 45 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.18104800 |
| 46 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.18101384 |
| 47 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.17286146 |
| 48 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.15805547 |
| 49 | Influenza A_Homo sapiens_hsa05164 | 1.13450613 |
| 50 | Hepatitis C_Homo sapiens_hsa05160 | 1.12236229 |
| 51 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.11202223 |
| 52 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.08839662 |
| 53 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.08341903 |
| 54 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.05782828 |
| 55 | Prion diseases_Homo sapiens_hsa05020 | 1.03510752 |
| 56 | Tuberculosis_Homo sapiens_hsa05152 | 1.02040629 |
| 57 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.01464413 |
| 58 | ABC transporters_Homo sapiens_hsa02010 | 1.00477072 |
| 59 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.99336524 |
| 60 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.99312059 |
| 61 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.99303227 |
| 62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.98702554 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.97234872 |
| 64 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.96512864 |
| 65 | HTLV-I infection_Homo sapiens_hsa05166 | 0.94860238 |
| 66 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.94674237 |
| 67 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.94352804 |
| 68 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.92728132 |
| 69 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.91901257 |
| 70 | Insulin secretion_Homo sapiens_hsa04911 | 0.91171467 |
| 71 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.91128646 |
| 72 | Measles_Homo sapiens_hsa05162 | 0.88932229 |
| 73 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.87596996 |
| 74 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.87411458 |
| 75 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.85275913 |
| 76 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.84457022 |
| 77 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.84254751 |
| 78 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.83406367 |
| 79 | Viral myocarditis_Homo sapiens_hsa05416 | 0.83043218 |
| 80 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.81574504 |
| 81 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.80679220 |
| 82 | Salmonella infection_Homo sapiens_hsa05132 | 0.80597984 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.79763341 |
| 84 | Peroxisome_Homo sapiens_hsa04146 | 0.79077845 |
| 85 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.77966625 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.77644439 |
| 87 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.77474216 |
| 88 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.77059714 |
| 89 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.75340689 |
| 90 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74477551 |
| 91 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.73341960 |
| 92 | Histidine metabolism_Homo sapiens_hsa00340 | 0.72654156 |
| 93 | Prostate cancer_Homo sapiens_hsa05215 | 0.72198283 |
| 94 | Malaria_Homo sapiens_hsa05144 | 0.72023669 |
| 95 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.71081549 |
| 96 | Endometrial cancer_Homo sapiens_hsa05213 | 0.71033692 |
| 97 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.70115146 |
| 98 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.69273634 |
| 99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.69075941 |
| 100 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.68530931 |
| 101 | Bladder cancer_Homo sapiens_hsa05219 | 0.68222282 |
| 102 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.68207862 |
| 103 | Galactose metabolism_Homo sapiens_hsa00052 | 0.67180247 |
| 104 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.66119863 |
| 105 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63835725 |
| 106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63488460 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.62950946 |
| 108 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.62415816 |
| 109 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61274124 |
| 110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59981540 |
| 111 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58885316 |
| 112 | Lysosome_Homo sapiens_hsa04142 | 0.57546816 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57428258 |
| 114 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.56806182 |
| 115 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.56553544 |
| 116 | Alcoholism_Homo sapiens_hsa05034 | 0.53842198 |
| 117 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.53488458 |
| 118 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.52754900 |
| 119 | Platelet activation_Homo sapiens_hsa04611 | 0.52372827 |
| 120 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.52068523 |
| 121 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51490297 |
| 122 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.51067744 |
| 123 | Melanoma_Homo sapiens_hsa05218 | 0.50947294 |
| 124 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.49931999 |
| 125 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49019296 |
| 126 | Pathways in cancer_Homo sapiens_hsa05200 | 0.48510100 |
| 127 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48507251 |
| 128 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.48001096 |
| 129 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47900529 |
| 130 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.47001270 |
| 131 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45082902 |
| 132 | Glioma_Homo sapiens_hsa05214 | 0.44764471 |
| 133 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.44706003 |
| 134 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.44543768 |
| 135 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.44350012 |
| 136 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.44313694 |
| 137 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.43945328 |
| 138 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.41801918 |
| 139 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.41134971 |
| 140 | Leishmaniasis_Homo sapiens_hsa05140 | 0.40509976 |
| 141 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.39176621 |
| 142 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.38091813 |
| 143 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.34169364 |
| 144 | Cocaine addiction_Homo sapiens_hsa05030 | 0.31582407 |
| 145 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.26620130 |
| 146 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.26021540 |
| 147 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.25628689 |
| 148 | Pertussis_Homo sapiens_hsa05133 | 0.25513580 |
| 149 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.24583869 |
| 150 | Thyroid cancer_Homo sapiens_hsa05216 | 0.24210593 |
| 151 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.23386463 |
| 152 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.21883148 |
| 153 | Amoebiasis_Homo sapiens_hsa05146 | 0.19605973 |

